SCHEMBL8287236

SCHEMBL8287236

CN(C)C(=O)CSc1cc2c(cn1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAT2A P31153 3/20 0.40
RECQL P46063 1/20 0.38
ALDH1A1 P00352 4/20 0.37
LMNA P02545 3/20 0.37
NPSR1 Q6W5P4 2/20 0.37
KDM4E B2RXH2 1/20 0.37
NPC1 O15118 2/20 0.37
GAA P10253 1/20 0.36
MAPK1 P28482 1/20 0.36
RAB9A P51151 2/20 0.36
TNK2 Q07912 1/20 0.35
EGFR P00533 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
TP53 P04637 1/20 0.34
TSHR P16473 1/20 0.34
MAPK8 P45983 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286498 0.89 GAA (0.47) ALDH1A1LMNAKDM4ENPC1GAA
SCHEMBL8285265 0.87 ALDH1A1 (0.46) ALDH1A1LMNANPC1RAB9AL3MBTL1
SCHEMBL8287235 0.87 NPC1 (0.49) ALDH1A1LMNANPSR1KDM4ENPC1
SCHEMBL8286471 0.85 PDE7A (0.38) MAT2AALDH1A1LMNANPSR1NPC1
SCHEMBL8287247 0.83 ALDH1A1 (0.46) ALDH1A1LMNAGAARAB9AL3MBTL1
SCHEMBL8287923 0.83 MAT2A (0.41) MAT2AMAPK1TNK2EGFRMAPK8
SCHEMBL8285328 0.82 GSK3B (0.38) MAT2AALDH1A1LMNAKDM4ENPC1
SCHEMBL8287515 0.82 BCL6 (0.40) MAT2ARECQLALDH1A1LMNAKDM4E
SCHEMBL8287481 0.82 MAT2A (0.49) MAT2AKDM4EGAAMAPK1TNK2
SCHEMBL8287949 0.79 GSK3B (0.40) MAT2AALDH1A1LMNANPC1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed